期刊论文详细信息
Revista Brasileira de Epidemiologia
Prescriptions for uncomplicated malaria treatment among pregnant women in the Brazilian Amazon: evidences from the Mafalda Project
Miranda, Elaine Silva1  Freitas, Letícia Figueira1  Luz, Tatiana Chama Borges2  Osório-de-Castro, Claudia Garcia Serpa1 
[1] Fundação Oswaldo Cruz, Rio de Janeiro, Brasil;Fundação Oswaldo Cruz, Belo Horizonte, Brasil
关键词: Malaria;    Plasmodium falciparum;    Plasmodium vivax;    Pregnant women;    Drug prescriptions;    Drug utilization;   
DOI  :  10.1590/S1415-790X2013000200016
学科分类:过敏症与临床免疫学
来源: SciELO
PDF
【 摘 要 】

Aim:To evaluate antimalarial prescriptions according to quality indicators and to describe adverse events reports among pregnant women with uncomplicated malaria.Methods:Descriptive study of medical files of pregnant women 15 years and older, residents in high-risk municipalities in the Brazilian Amazon. Antimalarial medicines were characterized by frequency of prescription, type of plasmodium and health care facilities where prescribing took place, and by possible adverse events. Variables were compared by Pearson’s chi-square.Results:A total of 262 medical files were evaluated. Most patients were diagnosed for Plasmodium vivax 71,2%. Chloroquine was the commonest prescribed antimalarial (65.6%). Of P. vivax prescriptions, 9.0%, and 16.2% of P. falciparum prescriptions presented antimalarials not recommended in the official protocol. Prescriptions for P. falciparum , in significantly higher proportion, did not adhere to the official protocol in regard to type of antimalarial and dose/duration of treatment (p = 0,001). They also lacked information on dose and dosing interval (p = 0,004). There were no significant differences among reference centers and basic health care units in respect to the prescribed antimalarials, to prescriptions containing antimalarials not recommended in the official protocol or in respect to lack of dosing information. Chloroquine was the antimalarial most related to the occurrence of adverse events.Conclusion:The findings indicate that there are flaws in antimalarial prescribing for pregnant women, especially in respect to their adequacy to the official protocol.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300723090ZK.pdf 294KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:19次